Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

24.100
+0.5502.34%
Volume:8.89M
Turnover:214.43M
Market Cap:143.32B
PE:30.67
High:24.400
Open:23.650
Low:23.650
Close:23.550
Loading ...

Hansoh Pharmaceutical Group Announces Breakthrough-Therapy Designation for B7-H4-Targeted ADC HS-20089 in China

Reuters
·
Yesterday

BRIEF-Hansoh Pharmaceutical Says NMPA Granted Breakthrough-Therapy-Designated Drug For HS-20089

Reuters
·
Yesterday

Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated Drug for B7-H4-Targeted Antibody-Drug Conjugate Hs-20089

THOMSON REUTERS
·
Yesterday

Hansoh Pharmaceutical Group Co. Ltd. Publishes 2024 Annual Report

Reuters
·
28 Apr

Hansoh Pharmaceutical Group Co. Ltd. Releases Environmental, Social and Governance Report

Reuters
·
28 Apr

Hansoh Pharmaceutical Gets China Nod to Register Vulvovaginal Candidiasis Drug

MT Newswires Live
·
28 Apr

BRIEF-Hansoh Pharmaceutical Receives Drug Registration Approval Of Hengmeida- (Ibrexafungerp Tablets)

Reuters
·
25 Apr

Hansoh Pharma's HS-20093 Drug Gets Another Breakthrough Therapy Designation in China

MT Newswires Live
·
18 Apr

BRIEF-Hansoh Pharmaceutical's Targeted Antibody Drug Conjugate Gets NMPA Breakthrough-Therapy-Designated-Drug

Reuters
·
17 Apr

Hansoh Pharmaceutical - Nmpa Granted Breakthrough-Therapy-Designated-Drug for B7-H3-Targeted Antibody-Drug Conjugate Hs-20093

THOMSON REUTERS
·
17 Apr

Hansoh Pharma Gets Clinical Trial Nod in China for Cancer Drug

MT Newswires Live
·
16 Apr

BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10529 Tablets Issued By NMPA

Reuters
·
15 Apr

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-10529 Tablets Issued by Nmpa

THOMSON REUTERS
·
15 Apr

Hansoh Pharmaceutical Gets China Nod for Trial of Two Tumor Drugs

MT Newswires Live
·
08 Apr

BRIEF-Hansoh Pharmaceutical Gains Clinical Trial Approval For HS-20108

Reuters
·
07 Apr

Hansoh Pharmaceutical - Clinical Trial Approval for Hs-20108 for Injection Issued by Nmpa

THOMSON REUTERS
·
07 Apr

Greater China Stocks Slip; Taiwan Sees Largest Decline

Dow Jones
·
31 Mar

Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.86 From HK$18.36, Keeps at Neutral

MT Newswires Live
·
24 Mar

Hansoh Pharmaceutical's 2024 Profit Jumps 33%

MT Newswires Live
·
24 Mar

BRIEF-Hansoh Pharmaceutical Posts FY Revenue Of RMB 12,261 Million

Reuters
·
21 Mar